Gaois

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

1 result

  1. SOCIAL QUESTIONS|health|pharmaceutical industry · PRODUCTION, TECHNOLOGY AND RESEARCH|research and intellectual property|research
    dreasacht tarraingthe Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Context 'Tacú le FSFM mar ardtosaíocht pholaitiúil i suíomhanna G7 agus G20, as a dtiocfaidh gealltanais uaillmhianacha ar an leibhéal domhanda, lena n-áirítear treoirphrionsabail a bhunú agus a mholadh chun go gcomhroinnfear go cothrom, i measc thíortha G20 nó G7, an t-ualach airgeadais a eascraíonn as dreasachtaí tarraingthe maidir le hábhair fhrithmhiocróbacha.' Reference "Togra le haghaidh Moladh maidir le dlús a chur le gníomhaíochtaí an Aontais chun an frithsheasmhacht in aghaidh ábhair fhrithmhiocróbacha a chomhrac trí chur chuige na hAon Sláinte Amháin, CELEX:52023DC0191/GA"
    dreasú tarraingthe Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Pull-Anreiz
    de
    pull incentive | pull incentive scheme
    en
    Definition incentive given to companies to invest in developing new antimicrobials which rewards successful results by increasing or ensuring future revenue Reference "COM-Terminology Coordination and COM-EN, based on:Christine Årdal, John-Arne Røttingen, Aleksandra Opalska, et al., 'Pull Incentives for Antibacterial Drug Development: An Analysis by the Transatlantic Task Force on Antimicrobial Resistance' (8.3.2023), Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 1378–1382"
    Comment "Funding for push incentives reduces the overall cost of research and development (R&D), and pull incentives ensure a viable market."